Kinnate Biopharma Inc.·4

Feb 16, 6:07 PM ET

Williams Richard Thomas 4

4 · Kinnate Biopharma Inc. · Filed Feb 16, 2021

Insider Transaction Report

Form 4
Period: 2021-02-12
Williams Richard Thomas
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-02-12+100,000100,000 total
    Exercise: $35.38Exp: 2031-02-12Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]The Option vests and becomes exercisable over time at the following rate: 1/48th of the total number of shares subject to the Option shall vest each month in equal installments starting on March 1, 2021.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION